Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease have?
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease has 1,062 citations in the OpenAlex counts ScholarIQ stores.
When was Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease published?
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease has 2018 year in the ScholarIQ index.
What is the open-access status of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease?
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease has bronze oa status in the ScholarIQ index.
What is the DOI of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease?
The DOI for Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease is on the source record.
What is the PMID of Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease?
The PMID for Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease is on the source record.
What is the OpenAlex record for Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease?
The OpenAlex for Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease is on the source record.